LTBP-2 inhibitors are a specialized class of compounds designed to target and inhibit the activity of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP-2). LTBP-2 is a member of the LTBP family of proteins that play a critical role in the regulation of transforming growth factor-beta (TGF-β) signaling, a key pathway involved in cellular growth, differentiation, and extracellular matrix (ECM) formation. Unlike other members of the LTBP family, LTBP-2 does not directly bind to TGF-β but instead interacts with the ECM and other structural components within the cellular environment. Inhibiting LTBP-2 offers researchers a unique tool to study its distinct role in ECM organization, the modulation of cell-matrix interactions, and its broader impact on cell signaling pathways.
The use of LTBP-2 inhibitors in scientific research is particularly valuable for exploring the non-TGF-β related functions of this protein, which are less understood compared to other LTBP family members. By inhibiting LTBP-2, researchers can disrupt its interactions within the ECM, allowing for a closer examination of how these interactions influence tissue architecture, cell adhesion, and mechanical signaling within various cellular contexts. Additionally, LTBP-2 inhibitors help to unravel the complexities of ECM dynamics, shedding light on how alterations in ECM composition and structure can affect cellular behavior and tissue integrity. This class of inhibitors is essential for advancing our understanding of ECM biology, providing insights into the intricate networks that maintain cellular and tissue homeostasis. Through the study of LTBP-2 inhibitors, researchers can gain a deeper appreciation of the multifaceted roles that ECM components play in regulating cell function and the overall maintenance of cellular environments.
| 제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF- & 베타; 경로를 표적으로 하여 잠복성 형질 전환 성장 인자 베타 결합 단백질(LTBP)에 간접적으로 영향을 줄 수 있습니다. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $105.00 $153.00 | 4 | |
또 다른 TGF- & 베타; 억제제; 또한 잠복성 형질 전환 성장 인자 베타 결합 단백질(LTBP)에 간접적으로 영향을 미칠 수 있습니다. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $165.00 $214.00 $396.00 $617.00 $4804.00 | 19 | |
또 다른 MMP 억제제; 잠복성 형질 전환 성장 인자 베타 결합 단백질(LTBP)에도 간접적으로 영향을 미칠 수 있습니다. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K/Akt/mTOR 억제제; 잠복성 형질 전환 성장 인자 베타 결합 단백질(LTBP)을 간접적으로 조절할 수 있습니다. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
또 다른 PI3K/Akt/mTOR 억제제; 잠복형 성장인자 베타 결합 단백질(LTBP)에도 간접적으로 영향을 미칠 수 있습니다. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR을 표적으로 하여 잠재적 형질 전환 성장 인자 베타 결합 단백질(LTBP)을 간접적으로 조절할 수 있습니다. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
또 다른 EGFR 억제제; 잠복형 성장 인자 베타 결합 단백질(LTBP)에도 간접적으로 영향을 미칠 수 있습니다. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1740.00 | ||
스매드3 억제제; 스매드 의존적 신호를 통해 잠복형 성장인자 베타 결합 단백질(LTBP)에 간접적으로 영향을 미칠 수 있습니다. | ||||||